Clinical practice guidelines: diagnosis and management chronic myeloproliferative disorders

Clinical practice guidelines: diagnosis and management chronic myeloproliferative disorders. Manual. Health Technology Assessment Unit, Kuala Lumpur, Malaysia. (2004)



Abstract

Myeloproliferative disorders (MPD) are chronic diseases caused by clonal proliferation of bone marrow stem cells leading to excess production of one or more haemopoietic lineages. The current classification of the MPD includes the following:
Polycythaemia rubra vera (PRV)
Essential thrombocythaemia (ET)
Myelofibrosis with myeloid metaplasia (MMM)
Unclassified
These four disorders are considered separate from chronic myeloid leukaemia (CML) and the myelodysplastic syndrome (MDS) with variable propensity to evolve into acute leukaemia. PRV and ET are associated with an increased risk of thrombosis.

Item Type: Monograph (Manual)
Keywords: Myeloproliferative Disorders, Clonal proliferation, Haematologic disorders, High cell counts, Bone marrow stem cells
Taxonomy: By Subject > Health Sciences > Medical Lab Technology > Hematology
Local Content Hub: Subjects > Health Sciences
Depositing User: Farleen Azrina Zamberi
Date Deposited: 05 Jul 2022 04:39
Last Modified: 05 Jul 2022 04:39
Related URLs:

Actions (login required)

View Item View Item